Anthony Gentile

Anthony Gentile has extensive experience in clinical operations and finance within the pharmaceutical industry, currently serving as the Director of Clinical Operations & Program Finance at Biohaven Pharmaceuticals since April 2018. Key responsibilities include serving as a liaison between R&D and Finance, managing budgets and financial forecasting for various departments, supporting business development with cost estimates, and overseeing project management for preclinical biologic assets. Prior to Biohaven, Gentile held multiple finance and management roles at Bristol-Myers Squibb, including Associate Director of Finance and Senior Protocol Manager, where responsibilities ranged from managing R&D financial alliances to conducting clinical trial management. Gentile's educational background includes a Bachelor of Science in Biology from Eastern Connecticut State University, an MBA in Finance from Rensselaer Polytechnic Institute, and a master's degree in Cell Biology and Anatomy from the University of Hartford.